Skip to main
ALT
ALT logo

Altimmune (ALT)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Altimmune (ALT) Stock

About Altimmune (ALT)

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherape...read more
Market cap$313.88M
Today's volume3.69M
Revenue (TTM)$20K
Avg. daily volume4.81M
EBITDA (TTM)-$98.03M
Open$3.84
Price / earnings ratio-3.09x
Today's range$3.77 - $4.02
Debt / equity1.12x
52 week range$2.9 - $11.16
5 year debt / equity0.56x
Beta (LTM)1.46x
Interest coverage-11463.56x
Dividend & yield$0.00 (0.00%)
Current ratio15.82x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

Altimmune Stock Rating

What analysts recommend for ALT stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 54%
Buy 31%
Hold 15%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for Altimmune stock is $313.89M

The current P/E ratio for Altimmune stock is -3.09

The 52-week high for Altimmune stock is $11.16. The current Altimmune stock price $undefined is 100.00% below its 52-week high

The 52-week low for Altimmune stock is $2.90. The current Altimmune stock price $undefined has increased 100.00% from its 52-week low

No, the Altimmune stock does not pay dividends to its shareholders

The target price for Altimmune stock is $20.33 based on the average of what a group of analyst think Altimmune stock could be worth at a future date. This is not a prediction by Public.com

How to buy Altimmune stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Altimmune stock

    Navigate to the Explore page. Then, type Altimmune into the search bar. When you see Altimmune stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Altimmune stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Altimmune Stock Earnings

The value each ALT share was expected to gain vs. the value that each ALT share actually gained.

Altimmune (ALT) reported Q1 2025 earnings per share (EPS) of -$0.26, beating estimates of -$0.35 by 25.71%. In the same quarter last year, Altimmune's earnings per share (EPS) was -$0.34. Altimmune is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of -$0.30.

Buy Altimmune (ALT) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.